CN103823072B - 体液中细胞成分的解离 - Google Patents
体液中细胞成分的解离 Download PDFInfo
- Publication number
- CN103823072B CN103823072B CN201410050570.1A CN201410050570A CN103823072B CN 103823072 B CN103823072 B CN 103823072B CN 201410050570 A CN201410050570 A CN 201410050570A CN 103823072 B CN103823072 B CN 103823072B
- Authority
- CN
- China
- Prior art keywords
- fluid
- cell
- purposes
- sample
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000003850 cellular structure Anatomy 0.000 title abstract description 31
- 210000001124 body fluid Anatomy 0.000 title description 7
- 239000010839 body fluid Substances 0.000 title description 7
- 238000000034 method Methods 0.000 claims abstract description 68
- 239000012472 biological sample Substances 0.000 claims abstract description 10
- 238000004140 cleaning Methods 0.000 claims description 20
- 239000003153 chemical reaction reagent Substances 0.000 claims description 16
- 239000002253 acid Substances 0.000 claims description 9
- 239000000243 solution Substances 0.000 claims description 9
- 238000012544 monitoring process Methods 0.000 claims description 5
- 239000012062 aqueous buffer Substances 0.000 claims description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 3
- 239000007853 buffer solution Substances 0.000 claims description 3
- 239000012459 cleaning agent Substances 0.000 claims description 3
- 229910021645 metal ion Inorganic materials 0.000 claims description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 2
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 claims description 2
- 239000010949 copper Substances 0.000 claims description 2
- 229910001431 copper ion Inorganic materials 0.000 claims description 2
- 229940095064 tartrate Drugs 0.000 claims description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims 1
- 229910052802 copper Inorganic materials 0.000 claims 1
- 239000004575 stone Substances 0.000 claims 1
- 239000012491 analyte Substances 0.000 abstract description 18
- 238000002360 preparation method Methods 0.000 abstract description 2
- 239000012530 fluid Substances 0.000 description 85
- 210000004369 blood Anatomy 0.000 description 53
- 239000008280 blood Substances 0.000 description 53
- 238000012545 processing Methods 0.000 description 52
- 239000000523 sample Substances 0.000 description 48
- 210000004027 cell Anatomy 0.000 description 32
- 238000007710 freezing Methods 0.000 description 27
- 230000008014 freezing Effects 0.000 description 26
- 238000010438 heat treatment Methods 0.000 description 23
- 239000000203 mixture Substances 0.000 description 17
- 206010018910 Haemolysis Diseases 0.000 description 14
- 230000008588 hemolysis Effects 0.000 description 14
- 239000007788 liquid Substances 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 13
- 238000001556 precipitation Methods 0.000 description 13
- 238000001816 cooling Methods 0.000 description 12
- 230000008021 deposition Effects 0.000 description 12
- 238000002414 normal-phase solid-phase extraction Methods 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- 210000003743 erythrocyte Anatomy 0.000 description 11
- 238000005070 sampling Methods 0.000 description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 239000000306 component Substances 0.000 description 7
- 238000010257 thawing Methods 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 210000001772 blood platelet Anatomy 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000003018 immunosuppressive agent Substances 0.000 description 5
- 229940124589 immunosuppressive drug Drugs 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 210000001768 subcellular fraction Anatomy 0.000 description 5
- 239000012808 vapor phase Substances 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 238000005336 cracking Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 210000002381 plasma Anatomy 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- 239000012620 biological material Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 238000010494 dissociation reaction Methods 0.000 description 3
- 230000005593 dissociations Effects 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- -1 phosphate anion Chemical class 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 2
- 229930105110 Cyclosporin A Natural products 0.000 description 2
- 108010036949 Cyclosporine Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 239000012503 blood component Substances 0.000 description 2
- 239000012930 cell culture fluid Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 2
- 229960001265 ciclosporin Drugs 0.000 description 2
- 229930182912 cyclosporin Natural products 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005111 flow chemistry technique Methods 0.000 description 2
- 238000005534 hematocrit Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- 238000000622 liquid--liquid extraction Methods 0.000 description 2
- 210000002751 lymph Anatomy 0.000 description 2
- 238000001906 matrix-assisted laser desorption--ionisation mass spectrometry Methods 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 2
- 229960002930 sirolimus Drugs 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- 238000010183 spectrum analysis Methods 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 241000370738 Chlorion Species 0.000 description 1
- VMQMZMRVKUZKQL-UHFFFAOYSA-N Cu+ Chemical compound [Cu+] VMQMZMRVKUZKQL-UHFFFAOYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 238000012369 In process control Methods 0.000 description 1
- 206010062018 Inborn error of metabolism Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 229910019093 NaOCl Inorganic materials 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- IOEJYZSZYUROLN-UHFFFAOYSA-M Sodium diethyldithiocarbamate Chemical compound [Na+].CCN(CC)C([S-])=S IOEJYZSZYUROLN-UHFFFAOYSA-M 0.000 description 1
- QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000011953 bioanalysis Methods 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000007824 enzymatic assay Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 102000018146 globin Human genes 0.000 description 1
- 108060003196 globin Proteins 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 239000000819 hypertonic solution Substances 0.000 description 1
- 229940021223 hypertonic solution Drugs 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000010965 in-process control Methods 0.000 description 1
- 208000016245 inborn errors of metabolism Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 239000001272 nitrous oxide Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 238000012123 point-of-care testing Methods 0.000 description 1
- 238000000247 postprecipitation Methods 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000001433 sodium tartrate Substances 0.000 description 1
- 229960002167 sodium tartrate Drugs 0.000 description 1
- 235000011004 sodium tartrates Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- QJJXYPPXXYFBGM-SHYZHZOCSA-N tacrolimus Natural products CO[C@H]1C[C@H](CC[C@@H]1O)C=C(C)[C@H]2OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](C[C@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC QJJXYPPXXYFBGM-SHYZHZOCSA-N 0.000 description 1
- 229960001967 tacrolimus Drugs 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Sampling And Sample Adjustment (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8363908P | 2008-07-25 | 2008-07-25 | |
| US61/083,639 | 2008-07-25 | ||
| EP08013447A EP2149793A1 (en) | 2008-07-25 | 2008-07-25 | Disintegration of cellular components in body fluids |
| EP08013447.1 | 2008-07-25 | ||
| CN200980129078.0A CN102105796B (zh) | 2008-07-25 | 2009-07-23 | 体液中细胞成分的解离 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200980129078.0A Division CN102105796B (zh) | 2008-07-25 | 2009-07-23 | 体液中细胞成分的解离 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103823072A CN103823072A (zh) | 2014-05-28 |
| CN103823072B true CN103823072B (zh) | 2016-05-11 |
Family
ID=39739776
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410050570.1A Expired - Fee Related CN103823072B (zh) | 2008-07-25 | 2009-07-23 | 体液中细胞成分的解离 |
| CN201510621231.9A Pending CN105258989A (zh) | 2008-07-25 | 2009-07-23 | 体液中细胞成分的解离 |
| CN200980129078.0A Expired - Fee Related CN102105796B (zh) | 2008-07-25 | 2009-07-23 | 体液中细胞成分的解离 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510621231.9A Pending CN105258989A (zh) | 2008-07-25 | 2009-07-23 | 体液中细胞成分的解离 |
| CN200980129078.0A Expired - Fee Related CN102105796B (zh) | 2008-07-25 | 2009-07-23 | 体液中细胞成分的解离 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9012137B2 (https=) |
| EP (2) | EP2149793A1 (https=) |
| JP (2) | JP2011529173A (https=) |
| CN (3) | CN103823072B (https=) |
| CA (1) | CA2731060A1 (https=) |
| WO (1) | WO2010009895A1 (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105258989A (zh) * | 2008-07-25 | 2016-01-20 | 萨莫芬尼根有限责任公司 | 体液中细胞成分的解离 |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9702864B2 (en) * | 2014-12-19 | 2017-07-11 | Thermo Finnigan Llc | Means for generating cell-disintegrated blood |
| WO2016140981A1 (en) * | 2015-03-02 | 2016-09-09 | Colonaryconcepts Llc | Compounds and methods for peg metabolite and peg breakdown product assays |
| SG10202105651UA (en) * | 2016-10-11 | 2021-07-29 | Haemokinesis Pty Ltd | Method for enhancing the incubation of samples, specimens and reagents using lasers |
| CN106706381B (zh) * | 2016-11-09 | 2019-04-12 | 桂林理工大学 | 植物亚细胞中总可溶性酚的分离提取方法 |
| KR20210019412A (ko) * | 2018-04-23 | 2021-02-22 | 유니버셀스 테크놀로지스 에스.에이. | 생성물 회수를 향상시키기 위한 동결-해동 기능을 구비한 생물반응기 및 관련 방법 |
| WO2020037128A1 (en) * | 2018-08-15 | 2020-02-20 | The Regents Of The University Of Michigan | Freeze concentration for urine-based fertilizer production |
| US11897822B2 (en) | 2019-11-07 | 2024-02-13 | The Regents Of The University Of Michigan | Reciprocating freeze concentration for urine-based fertilizer production |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006081185A1 (en) * | 2005-01-27 | 2006-08-03 | Neogen Corporation | Protein assay method and test device |
| CN101105457A (zh) * | 2007-07-30 | 2008-01-16 | 南昌大学 | 一种改良bca-紫外结合法测定氨苄青霉素人工抗原偶联率的方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5151348A (en) * | 1988-12-23 | 1992-09-29 | E. I. Du Pont De Nemours And Company | Enzyme-linked immunoassay for measurement of cyclosporin a levels in whole blood samples |
| JPH04300896A (ja) * | 1991-03-29 | 1992-10-23 | Hiroshi Sueoka | ヒト由来の早期妊娠因子及びその分離・精製法 |
| US6403376B1 (en) * | 1998-11-16 | 2002-06-11 | General Hospital Corporation | Ultra rapid freezing for cell cryopreservation |
| JP3614016B2 (ja) * | 1999-02-01 | 2005-01-26 | ニプロ株式会社 | 凍結細胞から有用細胞を回収する方法およびそのための器具 |
| US6623945B1 (en) | 1999-09-16 | 2003-09-23 | Motorola, Inc. | System and method for microwave cell lysing of small samples |
| JP3779885B2 (ja) * | 2001-03-26 | 2006-05-31 | 株式会社堀場製作所 | 免疫測定方法 |
| CN1381239A (zh) * | 2001-04-18 | 2002-11-27 | 松元司 | 由培养的白细胞提取成分的方法 |
| JP2004117127A (ja) * | 2002-09-25 | 2004-04-15 | Limuloid Science Kk | 血液エンドトキシン測定方法 |
| GB0325483D0 (en) * | 2003-10-31 | 2003-12-03 | Plasmacute As | Assay |
| WO2008003451A1 (en) | 2006-07-03 | 2008-01-10 | Sebo Gmbh | A method and device for processing a biological fluid for analyte determination |
| EP2149793A1 (en) * | 2008-07-25 | 2010-02-03 | SeBo GmbH | Disintegration of cellular components in body fluids |
-
2008
- 2008-07-25 EP EP08013447A patent/EP2149793A1/en not_active Ceased
-
2009
- 2009-07-23 WO PCT/EP2009/005388 patent/WO2010009895A1/en not_active Ceased
- 2009-07-23 US US13/003,859 patent/US9012137B2/en not_active Expired - Fee Related
- 2009-07-23 CN CN201410050570.1A patent/CN103823072B/zh not_active Expired - Fee Related
- 2009-07-23 CN CN201510621231.9A patent/CN105258989A/zh active Pending
- 2009-07-23 EP EP09800016.9A patent/EP2310863B1/en not_active Not-in-force
- 2009-07-23 JP JP2011519087A patent/JP2011529173A/ja active Pending
- 2009-07-23 CA CA2731060A patent/CA2731060A1/en not_active Abandoned
- 2009-07-23 CN CN200980129078.0A patent/CN102105796B/zh not_active Expired - Fee Related
-
2013
- 2013-05-01 JP JP2013096139A patent/JP2013174610A/ja active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006081185A1 (en) * | 2005-01-27 | 2006-08-03 | Neogen Corporation | Protein assay method and test device |
| CN101105457A (zh) * | 2007-07-30 | 2008-01-16 | 南昌大学 | 一种改良bca-紫外结合法测定氨苄青霉素人工抗原偶联率的方法 |
Non-Patent Citations (1)
| Title |
|---|
| The sensitivity of approved Ninhydrin and Biuret tests in the assessment of protein contamination on surgical steel as an aid to prevent iatrogenic prion transmission;I.P. Lipscomb et al;《Journal of Hospital Infection》;20060918;第64卷(第3期);第288-292页 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105258989A (zh) * | 2008-07-25 | 2016-01-20 | 萨莫芬尼根有限责任公司 | 体液中细胞成分的解离 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102105796B (zh) | 2015-10-14 |
| US9012137B2 (en) | 2015-04-21 |
| CN102105796A (zh) | 2011-06-22 |
| JP2011529173A (ja) | 2011-12-01 |
| EP2149793A1 (en) | 2010-02-03 |
| CA2731060A1 (en) | 2010-01-28 |
| JP2013174610A (ja) | 2013-09-05 |
| WO2010009895A1 (en) | 2010-01-28 |
| EP2310863A1 (en) | 2011-04-20 |
| US20110229870A1 (en) | 2011-09-22 |
| CN105258989A (zh) | 2016-01-20 |
| EP2310863B1 (en) | 2015-01-21 |
| CN103823072A (zh) | 2014-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103823072B (zh) | 体液中细胞成分的解离 | |
| JP4965651B2 (ja) | 核酸増幅装置を用いた核酸含有液体サンプル分析用使い捨て装置 | |
| US8231838B2 (en) | Method and device for processing a biological fluid for analyte determination | |
| JP2001516731A (ja) | 核酸を単離するための装置および方法 | |
| JPH0559380B2 (https=) | ||
| CN101273267A (zh) | 样品溶液中白蛋白的分析方法 | |
| Burguera et al. | In vivo sample uptake and on-line measurements of cobalt in whole blood by microwave-assisted mineralization and flow injection electrothermal atomic absorption spectrometry | |
| CN103675085B (zh) | 一种检测人血清中免疫球蛋白n糖链结构的方法 | |
| JP2021535380A (ja) | 糖尿病におけるマイクロサンプリング検出 | |
| US20070196813A1 (en) | Extraction of substances of interest from blood for mass spectrometric analysis | |
| JP3018032B2 (ja) | グリコヘモグロビンの自動測定方法 | |
| US20120107804A1 (en) | Disintegration of cellular components in body fluids | |
| EP1876450B1 (en) | A method for processing whole blood for analyte determination | |
| HK1147313A (en) | A method and device for processing a biological fluid for analyte determination | |
| CN116297917A (zh) | 一种鸡关节部位游离替米考星浓度的检测方法 | |
| JP2003083948A (ja) | 有機リン系物質検出用キットおよび簡易検出方法 | |
| Furuwatari et al. | Clinical evaluation of RT-PCR method for detection of HCV-RNA: second report availability of RT-PCR system using PCR internal control for detection of HCV-RNA and the influence of interfering substances on the detection | |
| JPH0798306A (ja) | 安定型糖化ヘモグロビン測定方法 | |
| Zhang et al. | Detection of Fluorescently Labeled Carbohydrate-Deficient Transferrin, a Marker of Alcohol Dependence, in Dried Blood Spots | |
| Liu et al. | Strategies for Method Developments in High Speed and Robust on-line Solid Phase Extraction- High Performance Liquid Chromatography- Tandem Mass Spectrometry | |
| MXPA96005601A (en) | Method and apparatus for the collection, storage and real-time analysis of the blood and othersfluides corpora |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160511 Termination date: 20180723 |